Bowel symptoms in patients that receive proton pump inhibitors. Results of a multicenter survey in Mexico
Introduction: Proton pump inhibitors (PPIs) have been associated with small intestinal bacterial overgrowth (SIBO), which increases with prolonged PPI use, and SIBO has been associated with irritable bowel syndrome (IBS). Objective: The aim of the present study was to study the prevalence of bowel s...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2019-01-01
|
| Series: | Revista de Gastroenterología de México (English Edition) |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2255534X18300598 |